Does ADAGRASIB Cause Multiple organ dysfunction syndrome? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Multiple organ dysfunction syndrome have been filed in association with ADAGRASIB (KRAZATI). This represents 1.0% of all adverse event reports for ADAGRASIB.
9
Reports of Multiple organ dysfunction syndrome with ADAGRASIB
1.0%
of all ADAGRASIB reports
9
Deaths
9
Hospitalizations
How Dangerous Is Multiple organ dysfunction syndrome From ADAGRASIB?
Of the 9 reports, 9 (100.0%) resulted in death, 9 (100.0%) required hospitalization, and 7 (77.8%) were considered life-threatening.
Is Multiple organ dysfunction syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADAGRASIB. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does ADAGRASIB Cause?
Death (272)
Diarrhoea (113)
Hospitalisation (108)
Nausea (87)
Vomiting (79)
Off label use (70)
Asthenia (61)
Fatigue (51)
Decreased appetite (43)
Dehydration (35)
What Other Drugs Cause Multiple organ dysfunction syndrome?
TACROLIMUS (1,847)
CYCLOPHOSPHAMIDE (1,597)
MYCOPHENOLATE MOFETIL (1,566)
PREDNISONE (1,525)
DEXAMETHASONE (1,355)
METHOTREXATE (1,317)
METHYLPREDNISOLONE (1,278)
RITUXIMAB (1,188)
PREDNISOLONE (1,154)
CYCLOSPORINE (933)
Which ADAGRASIB Alternatives Have Lower Multiple organ dysfunction syndrome Risk?
ADAGRASIB vs ADALIMUMAB
ADAGRASIB vs ADALIMUMAB-AACF
ADAGRASIB vs ADALIMUMAB-AATY
ADAGRASIB vs ADALIMUMAB-ADAZ
ADAGRASIB vs ADALIMUMAB-ADBM